Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States

Clinical Infectious Diseases

Volumn 42, Issue 4, 2006, Pages 441-447

  Shulman, Stanford T ^a,e   Stollerman, Gene ^d   Beall, Bernard ^b   Dale, James B ^c   Tanz, Robert R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Division of Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN;

ADOLESCENT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENOTYPE; HOST SUSCEPTIBILITY; HUMAN; INCIDENCE; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL; RHEUMATIC FEVER; SEROTYPE; STREPTOCOCCUS GROUP A; UNITED STATES;

ACUTE DISEASE; ADOLESCENT; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHICAGO; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; GENOTYPE; HUMANS; INCIDENCE; PHARYNGITIS; PREVALENCE; RHEUMATIC FEVER; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TIME FACTORS; UNITED STATES;

EID: 32044437411     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/499812     Document Type: Article

References (49)

1. Denny F. History of hemolytic streptococci and associated diseases. In: Stevens DL, Kaplan E, eds. Streptococcal infections. New York: Oxford University Press, 2000:1-18.
2. Gordis L. The virtual disappearance of rheumatic fever in the US: TD Jones Memorial Lecture. Circulation 1985; 72:1155-62.
3. Levinson SS, Beafield JL, Ausbrook DK, et al. The Chicago rheumatic fever program: a 20-plus year history. J Chronic Dis 1982; 35:199-206.
4. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the US. N Engl J Med 1987; 316:421-7.
5. Congeni B, Rizzo C, Congeni J, Sreenivasan W. Outbreak of acute rheumatic fever in northeast Ohio. J Pediatr 1987; 111:176-9.
6. Hosier DM, Craenen JM, Teske DW, Wheller JJ. Resurgence of acute rheumatic fever. Amer J Dis Child 1987; 141:730-3.
7. Wald ER, Dashefsky B, Feidt C, Chiponis D, Byers C. Acute rheumatic fever in western Pennsylvania and the tri-state area. Pediatrics 1987; 80:371-4.
8. Centers for Disease Control. Acute rheumatic fever among army trainees-Ft. Leonard Wood, MO, 1987-1988. MMWR Morb Mortal Wkly Rep 1988; 37:519.
9. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the US. J Pediatr 1994; 124:9-16.
10. Ayoub EM. The search for host determinants of susceptibility to rheumatic fever: the missing link. TD Jones Memorial Lecture. Circulation 1984; 69:197-201.
11. Ayoub EM, Kotb M, Cunningham MW. Rheumatic fever pathogenesis. In: Stevens DL, Kaplan E, eds. Streptococcal infections. New York: Oxford University Press, 2000:102-32.
12. Stollerman GH. Nephritogenic and rheumatogenic group A streptococci. J Infect Dis 1969; 120:258-63.
13. Stollerman GH. Rheumatogenic and nephritogenic streptococci. Circulation 1971; 43:915-21.
14. Bisno A. The concept of rheumatogenic and non-rheumatogenic group A streptococci. In: Read SE, Zabriskie JB, eds. Streptococcal disease and the immune response. New York: Academic Press, 1980:789-803.
15. Kuttner AG, Krumweide E. Observations on the effect of streptococcal upper respiratory infections on rheumatic children. A three-year study. J Clin Invest 1941; 20:273-87.
16. Bloomfield AL, Rantz LH. An outbreak of streptococcic septic sore throat in an army camp: clinical and epidemiologic observations. JAMA 1943; 121:315-9.
17. Stollerman GH. The return of rheumatic fever. Hosp Pract (Off Ed) 1988; 23:100-13.
18. Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis 2001; 33:806-14.
19. Stollerman GH, Siegel AC, Johnson EE. Variable epidemiology of streptococcal disease and the changing patterns of rheumatic fever. Mod Concepts Cardiovasc Dis 1965; 34:45.
20. Stollerman GH. The relative rheumatogenicity of strains of group A streptococci. Mod Concepts Cardiovasc Dis 1975; 44:35-40.
21. Stollerman GH: Streptococcus pyogenes. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. 3rd ed. Philadelphia: Lippencott, Williams & Wilkins, 2004:1591-604.
22. Veasy LG, Tani LY, Daly JA, et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004; 113: e168-72.
23. Shulman ST, Tanz RR, Kabat W, et al. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis 2004; 39:325-32.
24. Tanz RR, Shulman ST, Kabat W, et al. US community-based surveillance of macrolide-resistant pharyngeal group A streptococci during two respiratory disease seasons. Clin Infect Dis 2004; 39:1794-801.
25. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. N Engl J Med 1961; 265:559-66.
26. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34:953-8.
27. Taranta A. A history of rheumatic fever (and of its idea). In: Narula J, Virmani R, Reddy KS, Tandon R, eds. Rheumatic fever. Washington DC: American Registry of Pathology, 1999:1-40.
28. Markowitz M. The changing picture of rheumatic fever. Arthritis Rheum 1977; 20:369-74.
29. Markowitz M. The decline of rheumatic fever: role of medical intervention. Lewis W. Wannamaker Memorial Lecture. J Pediatr 1985; 106: 545-50.
30. Maxted WR, Valkenburg HA. Variation in the M antigen of group A streptococci. J Med Microbiol 1969; 2:199-210.
31. Widdowson JP. The M-associated protein antigens of group A streptococci. In: Read SE, Zabriskie JB, eds. Streptococcal disease and the immune response. New York: Academic Press, 1980:125-47.
32. Coburn AF, Pauli RH. Studies on the immune response of the rheumatic subject. J Clin Invest 1935; 14:755-62.
33. Bisno AL, Pearce IA, Wall HP, Moody MD, Stollerman GH. Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis. New Engl J Med 1970; 283:561-5.
34. Bessen D, Jones KF, Fischetti VA. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989; 169:269-83.
35. Whatmore AM, Kapur V, Sullivan DJ, Musser JM, Kehoe MA. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol Microbiol 1994; 14:619-31.
36. Marcon MJ, Hribar MM, Hosier DM, et al. Occurrence of mucoid M18 Streptococcus pyogenes in a central Ohio pediatric population. J Clin Microbiol 1988; 26:1539-42.
37. Kaplan EL, Johnson DR, Cleary PP. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the US in the mid-1980s. J Infect Dis 1989; 159: 101-3.
38. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infection, rheumatic fever or uncomplicated pharyngitis. J Infect Dis 1992; 166: 374-82.
39. Miner LJ, Petheram SJ, Daly JA, et al. Molecular-characterization of Streptococcus pyogenes isolates collected during-periods of increased acute rheumatic fever activity in Utah. Pediatr Infect Dis J 2004; 23: 56-61.
40. Smoot JC, Korgenski EK, Daly JA, Veasy LG, Musser JM. Molecular analysis of group A streptococcus type emm 18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 2002; 40:1805-10.
41. Smoot JC, Barbian KD, Van Compel JJ, et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. PNAS 2002; 99:4668-73.
42. Quinn RW, Denny FW, Riley HD. Natural occurrence of hemolytic streptococci in normal schoolchildren. Amer J Public Health 1957; 47: 995-1008.
43. Martin DR, Single LA. Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 1993; 167:1112-7.
44. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serogroup M1 protein. Infect Immun 1995; 63:994-1003.
45. Penney TJ, Martin DR, William LC. A single emm gene-specific oligonucleotide probe does not recognize all members of the Streptococcus pyogenes M type 1. FEMS Microbiol Lett 1995; 130:145-50.
46. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among serogroup M1 strains of Streptococcus pyogenes. In: Ferretii JJ, Gilmore MS, eds. Development Biol Stand (vol. 85). Basel, Switzerland: Karger, 1995:209-13.
47. Harbaugh MP, Podbielski A, Hügl S, Cleary PP. Nucleotide substitutions and small-scale insertions produce size and antigenic variation in group A streptococcal M1 protein. Mol Microbiol 1993; 8:981-91.
48. de Malmanche SA, Martin DR. Protective immunity to the group A streptococcus may be only strain-specific. Med Microbiol Immunol (Berl) 1994; 183:299-306.
49. Villaseñor-Sierra A, McShan WM, Salmi D, Kaplan EL, Johnson DR, Stevens DL. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera. J Infect Dis 1999;180:1921-8.